Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2.

Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2. Abstract Text:

    li congLi Cong,jessica gasserJessica Gasser,jessica zhaoJessica Zhao,baofeng yangBaofeng Yang,fanghong liFanghong Li,allan z zhaoAllan Z Zhao,li congLi Cong,jessica gasserJessica Gasser,jessica zhaoJessica Zhao,baofeng yangBaofeng Yang,fanghong liFanghong Li,allan z zhaoAllan Z Zhao,li congLi Cong,jessica gasserJessica Gasser,jessica zhaoJessica Zhao,baofeng yangBaofeng Yang,fanghong liFanghong Li,allan z zhaoAllan Z Zhao,

    Obesity is one of the well-established risk factors for endometrial cancer. Recent clinical studies have demonstrated that circulating adiponectin concentrations are inversely correlated with the incidence of endometrial carcinoma. Such epidemiological findings are consistent with the paradoxical observations that adiponectin levels are reduced in obesity. This study investigated the direct effects of adiponectin on two endometrial carcinoma cell lines, HEC-1-A and RL95-2. These cell lines express both variants of adiponectin receptors, adipo-R1 and adipo-R2. Adiponectin treatment leads to suppression of cell proliferation in both cell types, which is primarily due to the significant increase of cell populations at G(1)/G(0)-phase and to the induction of apoptosis. The inhibition of growth in these two cell lines appears to be mediated by different signaling pathways. Although adiponectin treatment markedly increases the phosphorylation (Thr172) of AMP-activated protein kinase alpha in both HEC-1-A and RL95-2 within 30 min, prolonged exposure (48 h) leads to inactivation of Akt as well as reduction of cyclin D1 protein expression in HEC-1-A cells. In contrast, similar treatment of RL95-2 cells with adiponectin, while having no effects on Akt activity and cyclin D1 expression, causes a decrease in cyclin E2 expression and the activity of mitogen-activated kinase (p42/44). We conclude that adiponectin exerts direct anti-proliferative effects on HEC-1-A and RL95-2 cells by inducing cell cycle arrest and apoptosis. Depending on the genotypes of the endometrial cancer cells, the inhibitory effects of adiponectin are associated with the reduction of different pro-growth regulators of cell cycle and signaling proteins. Our study thus provides a cellular mechanism underlying the linkages between endometrial cancer and obesity.

    Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2. Publishing Authors By Initials

    l congL Cong,j gasserJ Gasser,j zhaoJ Zhao,b yangB Yang,f liF Li,az zhaoAZ Zhao,l congL Cong,j gasserJ Gasser,j zhaoJ Zhao,b yangB Yang,f liF Li,az zhaoAZ Zhao,l congL Cong,j gasserJ Gasser,j zhaoJ Zhao,b yangB Yang,f liF Li,az zhaoAZ Zhao,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Endocrine-related cancer

    VOLUME: 14

    Page Numbers: 713-20

    Journal Abbreviation: Endocr. Relat. Cancer

    ISSN: 1351-0088

    DAY: 4

    MONTH: Sep

    YEAR: 2007

    Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9436481

    Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2.

    AFFILIATION: Department of Cell Biology and Physiology, University of Pittsburgh, S-326, BSTWR, 3500 Terrace Street, Pittsburgh, Pennsylvania 15261, USA.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY: United States NIDDK

    GRANT: 5P30 DK046204

    ACRONYM: DK

    MEDLINETA: Endocr Relat Cancer

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2 Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News